| Author |
Message |
Yahoo News Bot
Joined: 01 Feb 2005
Posts: 33941
|
 Posted:
Thu Mar 10, 2005 10:30 am |
  |
Reuters - Bristol-Myers Squibb Co.'s.
experimental drug for chronic hepatitis B infection is
effective in treating the liver disease, but also raises
questions about cancer risks, U.S. regulatory staff said in
documents released on Thursday.
Read more... |
|
|
|
|
|
|
| |
